Somerset Group’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-31,326
Closed -$4.43M 65
2018
Q3
$4.43M Buy
+31,326
New +$4.74M 3.56% 6
2016
Q4
Sell
-31,429
Closed -$2.56M 71
2016
Q3
$2.56M Buy
31,429
+110
+0.4% +$10.8K 2.63% 6
2016
Q2
$2.26M Sell
31,319
-1,566
-5% -$144K 2.36% 8
2016
Q1
$2.25M Sell
32,885
-307
-0.9% -$27K 2.44% 8
2015
Q4
$2.48M Buy
+33,192
New +$3.57M 2.62% 6
2015
Q3
Sell
-32,694
Closed -$2.2M 71
2015
Q2
$2.2M Sell
32,694
-1,208
-4% -$146K 2.1% 9
2015
Q1
$2.2M Sell
33,902
-699
-2% -$79K 1.97% 14
2014
Q4
$2.12M Buy
+34,601
New +$3.38M 1.89% 16

Other funds holding FBT

Somerset Group's FBT Position: Q4 2018 in Review

Somerset Group sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q4 2018, closing a stake of 31,326 shares — an estimated $4.43M sold.

Somerset Group first reported a position in FBT in Q4 2014 and held it in 8 quarters. The position peaked at $4.43M in Q3 2018. 194 funds tracked by Wall St. Rank hold FBT as of Q4 2018.

  • Somerset Group reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q4 2018 after selling out during the quarter.
  • Somerset Group sold 31,326 First Trust NYSE Arca Biotechnology Index Fund shares in Q4 2018, an estimated $4.43M.
  • Somerset Group first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2014 and held it in 8 quarters.
  • Somerset Group's First Trust NYSE Arca Biotechnology Index Fund position peaked at $4.43M in Q3 2018.
  • 194 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q4 2018.

Based on Somerset Group's 13F filing for Q4 2018, filed 11 Feb 2019.